262 related articles for article (PubMed ID: 17374617)
21. A novel method to display [gal alpha1, 3 gal] antigens on human leukemic cells for preparation of anti-leukemia vaccines.
Posekany KJ; Wiley JE; Gagnon GA
Anticancer Res; 2009 Jun; 29(6):2387-92. PubMed ID: 19528506
[TBL] [Abstract][Full Text] [Related]
22. A mutant chaperone converts a wild-type protein into a tumor-specific antigen.
Schietinger A; Philip M; Yoshida BA; Azadi P; Liu H; Meredith SC; Schreiber H
Science; 2006 Oct; 314(5797):304-8. PubMed ID: 17038624
[TBL] [Abstract][Full Text] [Related]
23. Enrichment of xenograft-competent genetically modified pig cells using a targeted toxin, isolectin BS-I-B4 conjugate.
Akasaka E; Watanabe S; Himaki T; Ohtsuka M; Yoshida M; Miyoshi K; Sato M
Xenotransplantation; 2010; 17(1):81-9. PubMed ID: 20149191
[TBL] [Abstract][Full Text] [Related]
24. Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing.
Yoshimura N; Sawada T; Furusawa M; Fuchinoue S
Cancer Lett; 2001 Mar; 164(2):155-60. PubMed ID: 11179830
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.
Van Elssen CH; Clausen H; Germeraad WT; Bennet EP; Menheere PP; Bos GM; Vanderlocht J
J Immunol Methods; 2011 Feb; 365(1-2):87-94. PubMed ID: 21194532
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic melanoma vaccine expressing alphaGal epitopes induces antitumor immunity to autologous antigens in mice without signs of toxicity.
Rossi GR; Mautino MR; Awwad DZ; Husske K; Lejukole H; Koenigsfeld M; Ramsey WJ; Vahanian N; Link CJ
J Immunother; 2008; 31(6):545-54. PubMed ID: 18528300
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody 16D10 to the C-terminal domain of the feto-acinar pancreatic protein binds to membrane of human pancreatic tumoral SOJ-6 cells and inhibits the growth of tumor xenografts.
Panicot-Dubois L; Aubert M; Franceschi C; Mas E; Silvy F; Crotte C; Bernard JP; Lombardo D; Sadoulet MO
Neoplasia; 2004; 6(6):713-24. PubMed ID: 15720797
[TBL] [Abstract][Full Text] [Related]
28. Human fetoacinar pancreatic protein: an oncofetal glycoform of the normally secreted pancreatic bile-salt-dependent lipase.
Mas E; Abouakil N; Roudani S; Miralles F; Guy-Crotte O; Figarella C; Escribano MJ; Lombardo D
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):609-15. PubMed ID: 8424803
[TBL] [Abstract][Full Text] [Related]
29. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients.
Kodar K; Kurtenkov O; Klaamas K
Immunol Invest; 2009; 38(8):704-17. PubMed ID: 19860583
[TBL] [Abstract][Full Text] [Related]
30. Anti-pig antibody adsorption efficacy of {alpha}-Gal carrying recombinant P-selectin glycoprotein ligand-1/immunoglobulin chimeras increases with core 2 {beta}1, 6-N-acetylglucosaminyltransferase expression.
Liu J; Gustafsson A; Breimer ME; Kussak A; Holgersson J
Glycobiology; 2005 Jun; 15(6):571-83. PubMed ID: 15625182
[TBL] [Abstract][Full Text] [Related]
31. Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodies.
Tinari N; D'Egidio M; Iacobelli S; Bowen M; Starling G; Seachord C; Darveau R; Aruffo A
Biochem Biophys Res Commun; 1997 Mar; 232(2):367-72. PubMed ID: 9125183
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody CC188 binds a carbohydrate epitope expressed on the surface of both colorectal cancer stem cells and their differentiated progeny.
Xu M; Yuan Y; Xia Y; Achilefu S
Clin Cancer Res; 2008 Nov; 14(22):7461-9. PubMed ID: 19010863
[TBL] [Abstract][Full Text] [Related]
33. Tk, a new colon tumor-associated antigen resulting from altered O-glycosylation.
Meichenin M; Rocher J; Galanina O; Bovin N; Nifantev N; Sherman A; Cassagnau E; Heymann MF; Bara J; Fraser RH; Le Pendu J
Cancer Res; 2000 Oct; 60(19):5499-507. PubMed ID: 11034094
[TBL] [Abstract][Full Text] [Related]
34. The influence of natural antibody specificity on antigen immunogenicity.
Benatuil L; Kaye J; Rich RF; Fishman JA; Green WR; Iacomini J
Eur J Immunol; 2005 Sep; 35(9):2638-47. PubMed ID: 16082726
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
[TBL] [Abstract][Full Text] [Related]
36. [Preparation and identification of monoclonal antibodies against different epitopes on TAG-72 antigen].
Xu M
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):431-4. PubMed ID: 7515344
[TBL] [Abstract][Full Text] [Related]
37. Potential target antigens for immunotherapy in human pancreatic cancer.
Schmitz-Winnenthal FH; Galindo-Escobedo LV; Rimoldi D; Geng W; Romero P; Koch M; Weitz J; Krempien R; Niethammer AG; Beckhove P; Buchler MW; Z'graggen K
Cancer Lett; 2007 Jul; 252(2):290-8. PubMed ID: 17320278
[TBL] [Abstract][Full Text] [Related]
38. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
[TBL] [Abstract][Full Text] [Related]
39. MMP11: a novel target antigen for cancer immunotherapy.
Peruzzi D; Mori F; Conforti A; Lazzaro D; De Rinaldis E; Ciliberto G; La Monica N; Aurisicchio L
Clin Cancer Res; 2009 Jun; 15(12):4104-13. PubMed ID: 19509157
[TBL] [Abstract][Full Text] [Related]
40. Humoral immune responses to tumor-associated carbohydrate antigens.
Lloyd KO
Semin Cancer Biol; 1991 Dec; 2(6):421-31. PubMed ID: 1725731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
